05:49 PM EDT, 03/23/2026 (MT Newswires) -- Sutro Biopharma ( STRO ) filed a registration statement late Monday for the sale of up to $300 million of securities from time to time.

The securities cover common and preferred stocks, debt securities, warrants, subscription rights, and units.

Net proceeds will be used for general corporate purposes.